2014
DOI: 10.4252/wjsc.v6.i2.120
|View full text |Cite
|
Sign up to set email alerts
|

Mesenchymal stem cells in the treatment of spinal cord injuries: A review

Abstract: With technological advances in basic research, the intricate mechanism of secondary delayed spinal cord injury (SCI) continues to unravel at a rapid pace. However, despite our deeper understanding of the molecular changes occurring after initial insult to the spinal cord, the cure for paralysis remains elusive. Current treatment of SCI is limited to early administration of high dose steroids to mitigate the harmful effect of cord edema that occurs after SCI and to reduce the cascade of secondary delayed SCI. R… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
137
0
7

Year Published

2015
2015
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 177 publications
(144 citation statements)
references
References 82 publications
0
137
0
7
Order By: Relevance
“…Therefore, rAT-MSCs and rBM-MSCs have the potential to support the regeneration process directly or indirectly. A number of studies on different types of animal models and on human subjects have demonstrated functional recovery by MSCs (1, 6,10,12,18,19,27,29).…”
Section: █ Introductionmentioning
confidence: 99%
“…Therefore, rAT-MSCs and rBM-MSCs have the potential to support the regeneration process directly or indirectly. A number of studies on different types of animal models and on human subjects have demonstrated functional recovery by MSCs (1, 6,10,12,18,19,27,29).…”
Section: █ Introductionmentioning
confidence: 99%
“…Another approach for enhancing the expansion of OECs is their reversible immortalization [Lim et al, 2010], and/or the application of induced pluripotent stem cells [Lee-Kubli and Lu, 2015], or even mesenchymal stem cells [Dasari et al, 2014]. We also noticed the smallest percentage of senescence cells and the highest percentage of living cells in the culture of the first group of donors when compared to the second group.…”
Section: Discussionmentioning
confidence: 51%
“…MSCs have been shown to differentiate into neural cells and astrocytes both in vitro and in vivo, exhibiting the ability to differentiate into astrocyte-like cells when transplanted into the normal or ischemic brain (24). However, despite these apparent abilities, the prevailing belief regarding the neuroprotective effects of MSCs is that of paracrine factors, which are secreted by these cells in response to damage (4,5,7). MSCs are known to secrete several growth factors, including brain-derived neurotrophic factor, vascular endothelial growth factor, neural growth factor, glia cell line-derived neurotrophic factor, and insulin-like growth factor, which play major roles in neuroprotection (5,25).…”
Section: Discussionmentioning
confidence: 99%